USE OF CICLOPIROX FOR THE TREATMENT OF CONGENITAL ERYTHROPOIETIC PORPHYRIA

摘要

The present invention relates to the use of the compound ciclopirox or a pharmaceutically acceptable salt or solvate thereof for the treatment and/or prevention of congenital erythropoietic porphyria (CEP).